2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
Volume 53, Issue 1, Pages 34-78
Publisher
Oxford University Press (OUP)
Online
2017-09-08
DOI
10.1093/ejcts/ezx334
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials
- (2017) Francesco Costa et al. LANCET
- Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6- or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial
- (2016) Giuseppe Gargiulo et al. AMERICAN HEART JOURNAL
- The Incremental Risk of Coronary Stents on Postoperative Adverse Events
- (2016) Carla N. Holcomb et al. ANNALS OF SURGERY
- Preoperative platelet function predicts perioperative bleeding complications in ticagrelor-treated cardiac surgery patients: a prospective observational study
- (2016) C.J. Malm et al. BRITISH JOURNAL OF ANAESTHESIA
- Short-versus long-term Dual Antiplatelet therapy after drug-eluting stent implantation in women versus men: A sex-specific patient-level pooled-analysis of six randomized trials
- (2016) Fadi J. Sawaya et al. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
- Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment StrategyClinical Perspective
- (2016) C. Michael Gibson et al. CIRCULATION
- Acute Limb Ischemia and Outcomes With Vorapaxar in Patients With Peripheral Artery DiseaseCLINICAL PERSPECTIVE
- (2016) Marc P. Bonaca et al. CIRCULATION
- Diabetes Mellitus and Prevention of Late Myocardial Infarction After Coronary Stenting in the Randomized Dual Antiplatelet Therapy StudyCLINICAL PERSPECTIVE
- (2016) Ian T. Meredith et al. CIRCULATION
- Six Versus 12 Months of Dual Antiplatelet Therapy After Implantation of Biodegradable Polymer Sirolimus-Eluting Stent
- (2016) Yaling Han et al. Circulation-Cardiovascular Interventions
- Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: conceptual evolution based on emerging evidence
- (2016) Tullio Palmerini et al. EUROPEAN HEART JOURNAL
- The effectiveness of platelet supplementation for the reversal of ticagrelor-induced inhibition of platelet aggregation
- (2016) Anne-Céline Martin et al. EUROPEAN JOURNAL OF ANAESTHESIOLOGY
- Coronary artery bypass grafting-related bleeding complications in patients treated with dual antiplatelet treatment
- (2016) Anton Tomšič et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
- (2016) Paulus Kirchhof et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- Duration of dual antiplatelet therapy after various drug-eluting stent implantation
- (2016) Abhishek Sharma et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Pharmacodynamic Effects of Switching From Prasugrel to Ticagrelor
- (2016) Francesco Franchi et al. JACC-Cardiovascular Interventions
- Impact of Sex on 2-Year Clinical Outcomes in Patients Treated With 6-Month or 24-Month Dual-Antiplatelet Therapy Duration
- (2016) Giuseppe Gargiulo et al. JACC-Cardiovascular Interventions
- Benefits and Risks of Extended Dual Antiplatelet Therapy After Everolimus-Eluting Stents
- (2016) James B. Hermiller et al. JACC-Cardiovascular Interventions
- Is Bare-Metal Stent Implantation Still Justifiable in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention?
- (2016) Sara Ariotti et al. JACC-Cardiovascular Interventions
- 6-Month Versus 12-Month Dual-Antiplatelet Therapy Following Long Everolimus-Eluting Stent Implantation
- (2016) Sung-Jin Hong et al. JACC-Cardiovascular Interventions
- Radial Versus Femoral Access for Coronary Interventions Across the Entire Spectrum of Patients With Coronary Artery Disease
- (2016) Giuseppe Ferrante et al. JACC-Cardiovascular Interventions
- Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention
- (2016) Robert W. Yeh et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Risk Associated With Surgery Within 12 Months After Coronary Drug-Eluting Stent Implantation
- (2016) Gro Egholm et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Reduction in Ischemic Events With Ticagrelor in Diabetic Patients With Prior Myocardial Infarction in PEGASUS–TIMI 54
- (2016) Deepak L. Bhatt et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCI
- (2016) Gennaro Giustino et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease
- (2016) John A. Bittl et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents
- (2016) Usman Baber et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease
- (2016) Marc P. Bonaca et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial
- (2016) Patrick W Serruys et al. LANCET
- Platelet function monitoring to adjust antiplatelet therapy in elderly patients stented for an acute coronary syndrome (ANTARCTIC): an open-label, blinded-endpoint, randomised controlled superiority trial
- (2016) Guillaume Cayla et al. LANCET
- Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials
- (2016) Salvatore Cassese et al. LANCET
- The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study
- (2016) Ziad Hijazi et al. LANCET
- Stopping vs. Continuing Aspirin before Coronary Artery Surgery
- (2016) Paul S. Myles et al. NEW ENGLAND JOURNAL OF MEDICINE
- Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease
- (2016) Kaare H. Bønaa et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI
- (2016) C. Michael Gibson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Current status of data on cangrelor
- (2016) Arman Qamar et al. PHARMACOLOGY & THERAPEUTICS
- Proton-pump inhibitors adverse effects: a review of the evidence and position statement by the Sociedad Española de Patología Digestiva
- (2016) Cristóbal de la Coba Ortiz et al. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
- Point-of-care genetic profiling and/or platelet function testing in acute coronary syndrome
- (2016) Jean-Philippe Collet et al. THROMBOSIS AND HAEMOSTASIS
- Bridge therapy or standard treatment for urgent surgery after coronary stent implantation: Analysis of 314 patients
- (2016) Stefano De Servi et al. VASCULAR PHARMACOLOGY
- Long-term ticagrelor monotherapy versus standard dual antiplatelet therapy followed by aspirin monotherapy in patients undergoing biolimus-eluting stent implantation: rationale and design of the GLOBAL LEADERS trial
- (2016) Pascal Vranckx et al. EuroIntervention
- Clinical factors associated with initiation of and persistence with ADP receptor-inhibiting oral antiplatelet treatment after acute coronary syndrome: a nationwide cohort study from Finland
- (2016) Tuire Prami et al. BMJ Open
- Prolonged vs Short Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With or Without Peripheral Arterial Disease
- (2016) Anna Franzone et al. JAMA Cardiology
- Safety of Preoperative Use of Ticagrelor With or Without Aspirin Compared With Aspirin Alone in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Grafting
- (2016) Riccardo Gherli et al. JAMA Cardiology
- Aspirin and coronary artery surgery: a systematic review and meta-analysis
- (2015) S. Hastings et al. BRITISH JOURNAL OF ANAESTHESIA
- Association of Discharge Aspirin Dose With Outcomes After Acute Myocardial InfarctionCLINICAL PERSPECTIVE
- (2015) Ying Xian et al. CIRCULATION
- Heart Disease and Stroke Statistics—2016 Update
- (2015) Dariush Mozaffarian et al. CIRCULATION
- Clinical Impact of Gastrointestinal Bleeding in Patients Undergoing Percutaneous Coronary Interventions
- (2015) K. C. Koskinas et al. Circulation-Cardiovascular Interventions
- Efficacy of Ex Vivo Autologous and In Vivo Platelet Transfusion in the Reversal of P2Y12 Inhibition by Clopidogrel, Prasugrel, and Ticagrelor: The APTITUDE Study
- (2015) S. A. O'Connor et al. Circulation-Cardiovascular Interventions
- Ischaemic risk and efficacy of ticagrelor in relation to time from P2Y12inhibitor withdrawal in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54
- (2015) Marc P. Bonaca et al. EUROPEAN HEART JOURNAL
- Coronary artery bypass grafting-related bleeding complications in patients treated with ticagrelor or clopidogrel: a nationwide study
- (2015) Emma C. Hansson et al. EUROPEAN HEART JOURNAL
- Report of a European Society of Cardiology-European Association of Percutaneous Cardiovascular Interventions task force on the evaluation of coronary stents in Europe: executive summary
- (2015) Robert A. Byrne et al. EUROPEAN HEART JOURNAL
- Impact of clinical presentation on ischaemic and bleeding outcomes in patients receiving 6- or 24-month duration of dual-antiplatelet therapy after stent implantation: a pre-specified analysis from the PRODIGY (Prolonging Dual-Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) trial
- (2015) F. Costa et al. EUROPEAN HEART JOURNAL
- Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention
- (2015) Dániel Aradi et al. EUROPEAN HEART JOURNAL
- ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting
- (2015) S. Schulz-Schupke et al. EUROPEAN HEART JOURNAL
- 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
- (2015) Marco Roffi et al. EUROPEAN HEART JOURNAL
- Impact of greater than 12-month dual antiplatelet therapy duration on mortality: Drug-specific or a class-effect? A meta-analysis
- (2015) Francesco Costa et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Antiplatelet Therapy Duration Following Bare Metal or Drug-Eluting Coronary Stents
- (2015) Dean J. Kereiakes et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction
- (2015) Robert W. Yeh et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 6- Versus 24-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents in Patients Nonresistant to Aspirin
- (2015) Martine Gilard et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation
- (2015) Katrin A. Fiedler et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Very Late Scaffold Thrombosis
- (2015) Lorenz Räber et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Zotarolimus-Eluting Versus Bare-Metal Stents in Uncertain Drug-Eluting Stent Candidates
- (2015) Marco Valgimigli et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A Prospective Randomized Trial of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis of Drug-Eluting Stents
- (2015) Fernando Alfonso et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation
- (2015) Gennaro Giustino et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of randomised trials
- (2015) Tullio Palmerini et al. LANCET
- Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial
- (2015) Marco Valgimigli et al. LANCET
- Switching P2Y12-receptor inhibitors in patients with coronary artery disease
- (2015) Fabiana Rollini et al. Nature Reviews Cardiology
- Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease
- (2015) Stephen G. Ellis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk
- (2015) Philip Urban et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
- (2015) Marc P. Bonaca et al. NEW ENGLAND JOURNAL OF MEDICINE
- Should dual antiplatelet therapy be used in patients following coronary artery bypass surgery? A meta-analysis of randomized controlled trials
- (2015) Subodh Verma et al. BMC Surgery
- Dual antiplatelet therapy duration after coronary stenting in clinical practice: results of an EAPCI survey
- (2015) Marco Valgimigli et al. EuroIntervention
- Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials
- (2015) E. P. Navarese et al. BMJ-British Medical Journal
- Prevalence and predictors of culprit plaque rupture at OCT in patients with coronary artery disease: a meta-analysis
- (2015) Mario Iannaccone et al. European Heart Journal-Cardiovascular Imaging
- Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials
- (2015) E. P. Navarese et al. BMJ-British Medical Journal
- Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population
- (2015) Nigam H. Shah et al. PLoS One
- Effect of preoperative P 2 Y 12 and thrombin platelet receptor inhibition on bleeding after cardiac surgery
- (2014) M. Ranucci et al. BRITISH JOURNAL OF ANAESTHESIA
- Antiplatelet Therapy for Stable Coronary Artery Disease in Atrial Fibrillation Patients Taking an Oral Anticoagulant
- (2014) Morten Lamberts et al. CIRCULATION
- Pretreatment with P2Y 12 Inhibitors in Non–ST-Segment–Elevation Acute Coronary Syndrome: An Outdated and Harmful Strategy
- (2014) Jean-Philippe Collet et al. CIRCULATION
- Pretreatment With P2Y 12 Inhibitors in Non–ST-Segment–Elevation Acute Coronary Syndrome Is Clinically Justified
- (2014) Marco Valgimigli CIRCULATION
- 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management
- (2014) EUROPEAN HEART JOURNAL
- 2014 ESC/EACTS Guidelines on myocardial revascularization
- (2014) EUROPEAN HEART JOURNAL
- 2014 ESC/EACTS Guidelines on myocardial revascularization
- (2014) Philippe Kolh et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- A Prospective, Multicenter, Randomized Trial of Paclitaxel-Coated Balloon Versus Paclitaxel-Eluting Stent for the Treatment of Drug-Eluting Stent In-Stent Restenosis
- (2014) Bo Xu et al. JACC-Cardiovascular Interventions
- Predictors and Outcomes of Recurrent Stent Thrombosis
- (2014) Ehrin J. Armstrong et al. JACC-Cardiovascular Interventions
- Second-Generation Drug-Eluting Stent Implantation Followed by 6- Versus 12-Month Dual Antiplatelet Therapy
- (2014) Antonio Colombo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery
- (2014) Lee A. Fleisher et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A Randomized Comparison of Drug-Eluting Balloon Versus Everolimus-Eluting Stent in Patients With Bare-Metal Stent–In-Stent Restenosis
- (2014) Fernando Alfonso et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Dual-antiplatelet treatment beyond 1 year after drug-eluting stent implantation (ARCTIC-Interruption): a randomised trial
- (2014) Jean-Philippe Collet et al. LANCET
- Prehospital Ticagrelor in ST-Segment Elevation Myocardial Infarction
- (2014) Gilles Montalescot et al. NEW ENGLAND JOURNAL OF MEDICINE
- Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents
- (2014) Laura Mauri et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Predictive Ability of the CHADS2 and CHA2DS2-VASc Scores for Bleeding Risk in Atrial Fibrillation: The MAQI2 Experience
- (2014) Geoffrey D. Barnes et al. THROMBOSIS RESEARCH
- Estimating The Value Of Cangrelor From Eliminating Preloading In Coronary Artery Bypass Graft (Cabg) Patients
- (2014) C. Bay et al. VALUE IN HEALTH
- Perioperative management of antiplatelet therapy in patients with coronary stents undergoing cardiac and non-cardiac surgery: a consensus document from Italian cardiological, surgical and anaesthesiological societies
- (2014) Roberta Rossini et al. EuroIntervention
- Effects of cobalt-chromium everolimus eluting stents or bare metal stent on fatal and non-fatal cardiovascular events: patient level meta-analysis
- (2014) M. Valgimigli et al. BMJ-British Medical Journal
- In-hospital switching of oral P2Y12 inhibitor treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention: Prevalence, predictors and short-term outcome
- (2013) Dimitrios Alexopoulos et al. AMERICAN HEART JOURNAL
- Meta-Analysis of Effect of Single Versus Dual Antiplatelet Therapy on Early Patency of Bypass Conduits After Coronary Artery Bypass Grafting
- (2013) Angelica G. Nocerino et al. AMERICAN JOURNAL OF CARDIOLOGY
- Aspirin to Prevent Cardiovascular Disease: The Association of Aspirin Dose and Clopidogrel With Thrombosis and Bleeding
- (2013) Steven R. Steinhubl ANNALS OF INTERNAL MEDICINE
- Effects of ex vivo platelet supplementation on platelet aggregability in blood samples from patients treated with acetylsalicylic acid, clopidogrel, or ticagrelor
- (2013) E.C. Hansson et al. BRITISH JOURNAL OF ANAESTHESIA
- Optimal Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation
- (2013) Cheol Whan Lee et al. CIRCULATION
- Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy
- (2013) Stefan Agewall et al. EUROPEAN HEART JOURNAL
- Should duration of dual antiplatelet therapy depend on the type and/or potency of implanted stent? A pre-specified analysis from the PROlonging Dual antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY (PRODIGY)
- (2013) M. Valgimigli et al. EUROPEAN HEART JOURNAL
- Switching Acute Coronary Syndrome Patients From Prasugrel to Clopidogrel
- (2013) Mathieu Kerneis et al. JACC-Cardiovascular Interventions
- Risk of Major Adverse Cardiac Events Following Noncardiac Surgery in Patients With Coronary Stents
- (2013) Mary T. Hawn et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Dual Anti-platelet Therapy After Coronary Artery Bypass Grafting: Is There Any Benefit? A Systematic Review and Meta-Analysis
- (2013) Salil V. Deo et al. JOURNAL OF CARDIAC SURGERY
- Nuisance Bleeding With Prolonged Dual Antiplatelet Therapy After Acute Myocardial Infarction and its Impact on Health Status
- (2013) Amit P. Amin et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Triple Therapy With Aspirin, Prasugrel, and Vitamin K Antagonists in Patients With Drug-Eluting Stent Implantation and an Indication for Oral Anticoagulation
- (2013) Nikolaus Sarafoff et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Oral Anticoagulation and Antiplatelets in Atrial Fibrillation Patients After Myocardial Infarction and Coronary Intervention
- (2013) Morten Lamberts et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The HAS-BLED Score Has Better Prediction Accuracy for Major Bleeding Than CHADS2 or CHA2DS2-VASc Scores in Anticoagulated Patients With Atrial Fibrillation
- (2013) Vanessa Roldán et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Patients With Stable Coronary Artery Disease
- (2013) Dominick J. Angiolillo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study
- (2013) Gregg W Stone et al. LANCET
- Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial
- (2013) Willem JM Dewilde et al. LANCET
- Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial
- (2013) Stephen D Wiviott et al. LANCET
- Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study
- (2013) Roxana Mehran et al. LANCET
- Pretreatment with Prasugrel in Non–ST-Segment Elevation Acute Coronary Syndromes
- (2013) Gilles Montalescot et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fibrinolysis or Primary PCI in ST-Segment Elevation Myocardial Infarction
- (2013) Paul W. Armstrong et al. NEW ENGLAND JOURNAL OF MEDICINE
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation
- (2013) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis
- (2013) E. P. Navarese et al. BMJ-British Medical Journal
- The Surgical Mortality Probability Model
- (2012) Laurent G. Glance et al. ANNALS OF SURGERY
- 2012 Update to The Society of Thoracic Surgeons Guideline on Use of Antiplatelet Drugs in Patients Having Cardiac and Noncardiac Operations
- (2012) Victor A. Ferraris et al. ANNALS OF THORACIC SURGERY
- Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary Stenting
- (2012) Marco Valgimigli et al. CIRCULATION
- Antiplatelet Therapy and Proton Pump Inhibition
- (2012) George V. Moukarbel et al. CIRCULATION
- Letter by De Miguel Castro et al Regarding Article, “Platelet Reactivity and Cardiovascular Outcomes After Percutaneous Coronary Intervention: A Time-Dependent Analysis of the Gauging Responsiveness With a VerifyNow P2Y12 Assay: Impact on Thrombosis and Safety (GRAVITAS) Trial”
- (2012) Antonio De Miguel Castro et al. CIRCULATION
- Bleeding After Initiation of Multiple Antithrombotic Drugs, Including Triple Therapy, in Atrial Fibrillation Patients Following Myocardial Infarction and Coronary Intervention
- (2012) Morten Lamberts et al. CIRCULATION
- Association of Proton Pump Inhibitor Use on Cardiovascular Outcomes With Clopidogrel and Ticagrelor
- (2012) Shaun G. Goodman et al. CIRCULATION
- Concomitant Use of Antiplatelet Therapy with Dabigatran or Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial
- (2012) Antonio L. Dans et al. CIRCULATION
- Platelet Function Measurement–Based Strategy to Reduce Bleeding and Waiting Time in Clopidogrel-Treated Patients Undergoing Coronary Artery Bypass Graft Surgery
- (2012) Elisabeth Mahla et al. Circulation-Cardiovascular Interventions
- ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
- (2012) et al. EUROPEAN HEART JOURNAL
- Aspirin plus clopidogrel for optimal platelet inhibition following off-pump coronary artery bypass surgery: results from the CRYSSA (prevention of Coronary arteRY bypaSS occlusion After off-pump procedures) randomised study
- (2012) Vito Antonio Mannacio et al. HEART
- Association of Clopidogrel Pretreatment With Mortality, Cardiovascular Events, and Major Bleeding Among Patients Undergoing Percutaneous Coronary Intervention
- (2012) Anne Bellemain-Appaix et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Bridging Antiplatelet Therapy With Cangrelor in Patients Undergoing Cardiac Surgery
- (2012) Dominick J. Angiolillo et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A New Strategy for Discontinuation of Dual Antiplatelet Therapy
- (2012) Byeong-Keuk Kim et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Mortality Benefit With Prasugrel in the TRITON–TIMI 38 Coronary Artery Bypass Grafting Cohort
- (2012) Peter K. Smith et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A Randomized Trial of Prasugrel Versus Clopidogrel in Patients With High Platelet Reactivity on Clopidogrel After Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stents
- (2012) Dietmar Trenk et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- SeQuent Please World Wide Registry
- (2012) Jochen Wöhrle et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial
- (2012) Renato D Lopes et al. LANCET
- Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI 50 trial
- (2012) Benjamin M Scirica et al. LANCET
- Point-of-care genetic testing for personalisation of antiplatelet treatment (RAPID GENE): a prospective, randomised, proof-of-concept trial
- (2012) Jason D Roberts et al. LANCET
- Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial
- (2012) Robert A Byrne et al. LANCET
- Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization
- (2012) Matthew T. Roe et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vorapaxar in the Secondary Prevention of Atherothrombotic Events
- (2012) David A. Morrow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bedside Monitoring to Adjust Antiplatelet Therapy for Coronary Stenting
- (2012) Jean-Philippe Collet et al. NEW ENGLAND JOURNAL OF MEDICINE
- In-Hospital Major Bleeding During ST-Elevation and Non–ST-Elevation Myocardial Infarction Care: Derivation and Validation of a Model from the ACTION Registry®-GWTG™
- (2011) Robin Mathews et al. AMERICAN JOURNAL OF CARDIOLOGY
- Ticagrelor Compared With Clopidogrel by Geographic Region in the Platelet Inhibition and Patient Outcomes (PLATO) Trial
- (2011) Kenneth W. Mahaffey et al. CIRCULATION
- Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents
- (2011) Hyeon-Cheol Gwon et al. CIRCULATION
- Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology
- (2011) P. G. Steg et al. EUROPEAN HEART JOURNAL
- Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial
- (2011) R. C. Becker et al. EUROPEAN HEART JOURNAL
- Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial
- (2011) J. Oldgren et al. EUROPEAN HEART JOURNAL
- Use of risk scores in acute coronary syndromes
- (2011) Héctor Bueno et al. HEART
- Standard- vs High-Dose Clopidogrel Based on Platelet Function Testing After Percutaneous Coronary Intervention
- (2011) Matthew J. Price JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
- (2011) Glenn N. Levine et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Earlier recovery of platelet function after discontinuation of treatment with ticagrelor compared with clopidogrel in patients with high antiplatelet responses
- (2011) R. F. STOREY et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multiple Electrode Whole-Blood Aggregometry and Bleeding in Cardiac Surgery Patients Receiving Thienopyridines
- (2010) Marco Ranucci et al. ANNALS OF THORACIC SURGERY
- Risk of Bleeding With Single, Dual, or Triple Therapy With Warfarin, Aspirin, and Clopidogrel in Patients With Atrial Fibrillation
- (2010) Morten L. Hansen et al. ARCHIVES OF INTERNAL MEDICINE
- Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of ‘bridging’ antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel
- (2010) S. Savonitto et al. BRITISH JOURNAL OF ANAESTHESIA
- Perioperative Management of Patients With Drug-Eluting Stents
- (2010) Ali O. Abualsaud et al. JACC-Cardiovascular Interventions
- Frequency of Major Noncardiac Surgery and Subsequent Adverse Events in the Year After Drug-Eluting Stent Placement
- (2010) Peter B. Berger et al. JACC-Cardiovascular Interventions
- Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI
- (2010) Jessica L. Mega et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Increased Platelet Inhibition After Switching From Maintenance Clopidogrel to Prasugrel in Patients With Acute Coronary Syndromes
- (2010) Dominick J. Angiolillo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A Risk Score to Predict Bleeding in Patients With Acute Coronary Syndromes
- (2010) Roxana Mehran et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Clopidogrel Responsiveness Regardless of the Discontinuation Date Predicts Increased Blood Loss and Transfusion Requirement After Off-Pump Coronary Artery Bypass Graft Surgery
- (2010) Young-Lan Kwak et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Consensus and Future Directions on the Definition of High On-Treatment Platelet Reactivity to Adenosine Diphosphate
- (2010) Laurent Bonello et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Impact of Cytochrome P450 2C19 Loss-of-Function Polymorphism and of Major Demographic Characteristics on Residual Platelet Function After Loading and Maintenance Treatment With Clopidogrel in Patients Undergoing Elective Coronary Stent Placement
- (2010) Willibald Hochholzer et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery
- (2010) Claes Held et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study
- (2010) Christopher P Cannon et al. LANCET
- Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial
- (2010) Shamir R Mehta et al. LANCET
- Clopidogrel with or without Omeprazole in Coronary Artery Disease
- (2010) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Timing of Noncardiac Surgery After Coronary Artery Stenting With Bare Metal or Drug-Eluting Stents
- (2009) Jan-Peter van Kuijk et al. AMERICAN JOURNAL OF CARDIOLOGY
- Drug–Drug Interaction Between Clopidogrel and the Proton Pump Inhibitors
- (2009) Nicholas B Norgard et al. ANNALS OF PHARMACOTHERAPY
- Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease
- (2009) Paul A. Gurbel et al. CIRCULATION
- Baseline Risk of Major Bleeding in Non–ST-Segment–Elevation Myocardial Infarction
- (2009) Sumeet Subherwal et al. CIRCULATION
- Patients with peripheral arterial disease in the CHARISMA trial
- (2009) P. P. Cacoub et al. EUROPEAN HEART JOURNAL
- P2Y12 inhibitors: differences in properties and mechanisms of action and potential consequences for clinical use
- (2009) L. Wallentin EUROPEAN HEART JOURNAL
- Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy
- (2009) Alan R. Shuldiner JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Predictors of Coronary Stent Thrombosis
- (2009) Jochem W. van Werkum et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial
- (2009) Ali S Taha et al. LANCET
- Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data
- (2009) Rikke Sørensen et al. LANCET
- Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials
- (2009) Michelle L O'Donoghue et al. LANCET
- Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial
- (2009) Gilles Montalescot et al. LANCET
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
- (2009) Lars Wallentin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Guidelines on the assessment of bleeding risk prior to surgery or invasive procedures.
- (2008) Y. L. Chee et al. BRITISH JOURNAL OF HAEMATOLOGY
- Effects of aspirin dose on ischaemic events and bleeding after percutaneous coronary intervention: insights from the PCI-CURE study
- (2008) S. S. Jolly et al. EUROPEAN HEART JOURNAL
- Effects of the Proton Pump Inhibitor Lansoprazole on the Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel
- (2008) David S. Small et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Prediction of One-Year Survival in High-Risk Patients with Acute Coronary Syndromes: Results from the SYNERGY Trial
- (2008) Kenneth W. Mahaffey et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Long-Term Outcomes by Clopidogrel Duration and Stent Type in a Diabetic Population With De Novo Coronary Artery Lesions
- (2008) Somjot S. Brar et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Periprocedural Bleeding and 1-Year Outcome After Percutaneous Coronary Interventions
- (2008) Gjin Ndrepepa et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Influence of Omeprazole on the Antiplatelet Action of Clopidogrel Associated With Aspirin
- (2008) Martine Gilard et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Clopidogrel-Associated Bleeding and Related Complications in Patients Undergoing Coronary Artery Bypass Grafting
- (2008) A. Simon Pickard et al. PHARMACOTHERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now